Olanzapine Zydis for PRN Use in Psychosomatic Catatonia and Shaking
Olanzapine Zydis (orally disintegrating tablet) can be used PRN for acute catatonia with agitation, but benzodiazepines remain the first-line treatment for catatonia itself, while olanzapine is better suited for managing severe psychomotor agitation or when benzodiazepines fail. 1
Treatment Algorithm for Catatonia with Agitation
First-Line Approach
- Start with benzodiazepines as the primary treatment for catatonia, specifically lorazepam 1-2 mg IV/SC/PO as the gold standard 1, 2
- Benzodiazepines typically produce symptom reduction within 24-72 hours in non-schizophrenic catatonia 3
- If lorazepam is unavailable, midazolam 2.5-5 mg IV/SC can be used as an alternative 1, 2
Role of Olanzapine Zydis
- Olanzapine 2.5-5 mg can be given PRN (stat dose) for severe psychomotor agitation that accompanies catatonia, particularly when the patient poses risk to self or others 1
- The orally disintegrating tablet (Zydis/ODT) formulation is specifically mentioned in guidelines as available and useful for patients who cannot swallow or are refusing oral medication 1
- Start with 2.5 mg in older or frail patients; standard starting dose is 2.5-5 mg 1
When to Use Olanzapine in Catatonia
Use olanzapine when:
- Benzodiazepines alone provide insufficient control of severe agitation 4
- The patient has schizophrenia with catatonic features (which is notoriously resistant to benzodiazepine monotherapy) 4
- Combination therapy may be needed: emerging evidence supports combining lorazepam with olanzapine for schizophrenia-related catatonia 4
Critical cautions:
- Conventional antipsychotics can worsen or induce malignant catatonia and should be avoided 5
- The safety profile of atypical antipsychotics like olanzapine in catatonia remains somewhat controversial, with case reports of both benefit and potential worsening 5, 3
- One case report documented a fatal malignant catatonia possibly associated with olanzapine 10 mg daily, though causality was unclear 5
Specific Dosing for PRN Use
For acute agitation with catatonia:
- Olanzapine Zydis 2.5-5 mg PO stat (single dose) 1
- Can repeat dosing, but scheduled dosing should only be used for persistent symptoms and for the shortest duration possible 1
- Reduce dose in elderly patients and those with hepatic impairment 1
For the "shaking" component:
- If tremor represents akathisia or extrapyramidal symptoms from prior antipsychotic use, olanzapine may actually help as it has lower EPS risk than typical antipsychotics 1
- If tremor is parkinsonian in nature from catatonia itself, benzodiazepines are preferred 1
Safety Considerations
Important warnings with olanzapine:
- May cause drowsiness and orthostatic hypotension (monitor blood pressure) 1
- Fatal respiratory depression and oversedation reported when combined with benzodiazepines - use extreme caution if combining 1
- Metabolic effects with long-term use (less relevant for PRN dosing) 1
- Use lower doses (2.5 mg) in elderly patients due to increased mortality risk in dementia-related psychosis 1
Clinical Decision Framework
Choose benzodiazepines alone when:
Add olanzapine Zydis PRN when:
- Severe agitation requires rapid control alongside catatonia treatment 1
- Benzodiazepines provide inadequate symptom control after 24-48 hours 4
- Patient has schizophrenia with catatonic features 4
Avoid olanzapine and consider ECT when:
- Malignant catatonia is suspected (fever, autonomic instability, rigidity) 5
- No response to benzodiazepines after 72 hours 5
- Life-threatening presentation 5
Common Pitfalls
- Do not use typical antipsychotics (haloperidol, chlorpromazine) for catatonia - they can precipitate malignant catatonia 5
- Do not assume all "shaking" is the same - differentiate between catatonic rigidity, parkinsonian tremor, akathisia, and anxiety-related tremor 1
- If combining olanzapine with benzodiazepines, start with lowest doses and monitor closely for respiratory depression 1
- Do not continue scheduled olanzapine long-term without reassessing need - PRN use is safer 1